Erich Solomayer

Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials

Carsten Denkert, Fenja Seither, Andreas Schneeweiß et al. · The Lancet Oncology · 2021 · 561 citations

Medicine, Cancer Biology, Oncology +16

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

Tanja Fehm, Volkmar Müller, Bahriye Aktas et al. · Breast Cancer Research and Treatment · 2010 · 357 citations

Medicine, Cancer Biology, Oncology +16

Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis

Wolfgang Janni, Florian D. Vogl, Gro Wiedswang et al. · Clinical Cancer Research · 2011 · 246 citations

Medicine, Oncology, Breast Oncology +15

Progression-Specific Genes Identified by Expression Profiling of Matched Ductal Carcinomas <i>In situ</i> and Invasive Breast Tumors, Combining Laser Capture Microdissection and Oligonucleotide Microarray Analysis

Christina S. Schuetz, Michael von Bonin, Susan E. Clare et al. · Cancer Research · 2006 · 241 citations · Full text

Medicine, Cancer Biology, Oncology +17

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

Tanja Fehm, Oliver Hoffmann, Bahriye Aktas et al. · Breast Cancer Research · 2009 · 240 citations · Full text

Medicine, Oncology, Pathology +16